A biopharmaceutical company that discovers, develops and manufactures antibodies and other genetically-engineered protein products to treat immunological and inflammatory disorders, cancer and infectious diseases.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
XOMA is exceptional. It's innovation intrigues me. Normally, I put pharmaceuticals in my too hard pile, but XOMA's innovative nature made it quite desirable. It has partnerships that beautifully exploit the strengths of each company, and has contracts from the federal government. The leadership has several successes under their belt, and it seems to be financially sound.